These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1076 related articles for article (PubMed ID: 17689729)

  • 1. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torsade de pointes: the clinical considerations.
    Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Torsade de pointes].
    Haverkamp W; Hördt M; Chen X; Hindricks G; Willems S; Kottkamp H; Rotman B; Brunn J; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Dec; 82(12):763-74. PubMed ID: 8147050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QT interval prolongation and ventricular fibrillation in childhood end-stage renal disease.
    Kim GB; Cho HY; Kwon BS; Bae EJ; Noh CI; Choi JY; Yun YS; Choi Y; Ha JW
    Int J Cardiol; 2008 Jul; 127(3):e126-8. PubMed ID: 17714808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acquired long QT syndrome with torsade de pointes in a patient with primary hypothyroidism].
    Kukla P; Szczuka K; Słowiak-Lewińska T; Bromblik A; Hajduk B; Kluczewski M; Lenard B; Przewor M
    Kardiol Pol; 2003 Mar; 58(3):224-6. PubMed ID: 14513098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT interval prolongation and torsade de pointes associated with indapamide. Comments to Letsas et al.
    Perciaccante A; Fiorentini A
    Int J Cardiol; 2007 Nov; 122(3):255; author reply 256-7. PubMed ID: 17368589
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical characteristics of 52 patients with torsade de points associated with acquired QT prolongation].
    Song L; Yang YM; Zhu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):293-6. PubMed ID: 21624301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsade de pointes, QT interval prolongation and renal disease.
    Patanè S
    Int J Cardiol; 2011 Jun; 149(2):241-242. PubMed ID: 21106259
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Torsades de pointes].
    Guize L; Iliou MC; Bayet G; Lavergne T; Le Heuzey JY
    Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):769-76. PubMed ID: 8267505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Torsades de pointes ventricular tachycardia caused by terodiline (Mictrol)?].
    Pedersen JL; Ohmsen E
    Ugeskr Laeger; 1992 Sep; 154(40):2760-1. PubMed ID: 1413214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Why is QT interval interesting?].
    Elming H; Sonne J; Lublin HK
    Ugeskr Laeger; 2002 Feb; 164(6):750-4. PubMed ID: 11851179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced long QT and torsade de pointes: recent advances.
    Kannankeril PJ; Roden DM
    Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracranial hemorrhage complicated by recurrent polymorphic ventricular torsade de pointes tachycardia].
    Kukla P; Bromblik A; Malecka-Tomasik D; Slowiak-Lewinska T
    Kardiol Pol; 2003 May; 58(5):390-3. PubMed ID: 14523488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
    Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
    Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes.
    Ghosh S; Apte P; Maroz N; Broor A; Zeineh N; Khan IA
    Int J Cardiol; 2009 Aug; 136(2):225-7. PubMed ID: 18617280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.